275 related articles for article (PubMed ID: 24400932)
21. Clinical Value of Serum Neuron-Specific Enolase Combined with Serum S100B Protein in the Diagnosis of Systemic Lupus Erythematosus.
Chen J; Yan Cheng ; Zhang X; Wang F; Chuai X
Contrast Media Mol Imaging; 2022; 2022():9390991. PubMed ID: 35615727
[TBL] [Abstract][Full Text] [Related]
22. [Value of serum S100B protein and neuron-specific enolase levels in predicting the severity of hand, foot and mouth disease].
Li J; Liu RH; Shan RB
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):182-187. PubMed ID: 28202117
[TBL] [Abstract][Full Text] [Related]
23. Serum NSE and S100B protein levels for evaluating the impaired consciousness in patients with acute carbon monoxide poisoning.
Zhang L; Zhao J; Hao Q; Xu X; Han H; Li J
Medicine (Baltimore); 2021 Jun; 100(25):e26458. PubMed ID: 34160445
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of S100B protein in the differential diagnosis of acute vertigo in the emergency department.
Kartal AG; Yılmaz S; Yaka E; Pekdemir M; Sarısoy HT; Çekmen MB; Yüksel M
Acad Emerg Med; 2014 Jul; 21(7):736-41. PubMed ID: 25125270
[TBL] [Abstract][Full Text] [Related]
25. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
Kaciński M; Budziszewska B; Lasoń W; Zając A; Skowronek-Bała B; Leśkiewicz M; Kubik A; Basta-Kaim A
Pharmacol Rep; 2012; 64(6):1427-33. PubMed ID: 23406753
[TBL] [Abstract][Full Text] [Related]
26. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
[TBL] [Abstract][Full Text] [Related]
28. Serum Neuronal Biomarkers in Neonates With Congenital Heart Disease Undergoing Cardiac Surgery.
Trakas E; Domnina Y; Panigrahy A; Baust T; Callahan PM; Morell VO; Munoz R; Bell MJ; Sanchez-de-Toledo J
Pediatr Neurol; 2017 Jul; 72():56-61. PubMed ID: 28571730
[TBL] [Abstract][Full Text] [Related]
29. S100B and NSE serum levels in obstructive sleep apnea syndrome.
Braga CW; Martinez D; Wofchuk S; Portela LV; Souza DO
Sleep Med; 2006 Aug; 7(5):431-5. PubMed ID: 16750933
[TBL] [Abstract][Full Text] [Related]
30. Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis.
Çatlı G; Anık A; Acar S; Küme T; Karabulut M; Çalan ÖG; Dündar BN; Abacı A
Pediatr Diabetes; 2018 Aug; 19(5):1000-1006. PubMed ID: 29484801
[TBL] [Abstract][Full Text] [Related]
31. S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.
Ondruschka B; Pohlers D; Sommer G; Schober K; Teupser D; Franke H; Dressler J
J Neurotrauma; 2013 Nov; 30(22):1862-71. PubMed ID: 23796187
[TBL] [Abstract][Full Text] [Related]
32. Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy.
Kanavaki A; Spengos K; Moraki M; Delaporta P; Kariyannis C; Papassotiriou I; Kattamis A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244749
[TBL] [Abstract][Full Text] [Related]
33. S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury.
Rodríguez-Rodríguez A; Egea-Guerrero JJ; Gordillo-Escobar E; Enamorado-Enamorado J; Hernández-García C; Ruiz de Azúa-López Z; Vilches-Arenas Á; Guerrero JM; Murillo-Cabezas F
Neurol Res; 2016 Feb; 38(2):130-7. PubMed ID: 27078699
[TBL] [Abstract][Full Text] [Related]
34. Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients.
González-García S; González-Quevedo A; Fernández-Concepción O; Peña-Sánchez M; Menéndez-Saínz C; Hernández-Díaz Z; Arteche-Prior M; Pando-Cabrera A; Fernández-Novales C
Clin Biochem; 2012 Nov; 45(16-17):1302-7. PubMed ID: 22820433
[TBL] [Abstract][Full Text] [Related]
35. Significance of serial S100b and NSE serum measurements in surgically treated patients with spondylotic cervical myelopathy.
Marquardt G; Setzer M; Szelenyi A; Seifert V; Gerlach R
Acta Neurochir (Wien); 2009 Nov; 151(11):1439-43. PubMed ID: 19499171
[TBL] [Abstract][Full Text] [Related]
36. The effect of obstructive sleep apnea syndrome on serum S100B and NSE levels: a systematic review and meta-analysis of observational studies.
Rezaei F; Abbasi H; Sadeghi M; Imani MM
BMC Pulm Med; 2020 Feb; 20(1):31. PubMed ID: 32024492
[TBL] [Abstract][Full Text] [Related]
37. Assessing mercury intoxication in isolated/remote populations: Increased S100B mRNA in blood in exposed riverine inhabitants of the Amazon.
de Paula Fonseca Arrifano G; Del Carmen Rodriguez Martin-Doimeadios R; Jiménez-Moreno M; Augusto-Oliveira M; Rogério Souza-Monteiro J; Paraense R; Rodrigues Machado C; Farina M; Macchi B; do Nascimento JLM; Crespo-Lopez ME
Neurotoxicology; 2018 Sep; 68():151-158. PubMed ID: 30076900
[TBL] [Abstract][Full Text] [Related]
38. [Effects of cattle encephalon glycoside and ignotin injection on serum level of S100B protein and neuron specific enolase in patients undergoing cardiac valve replacement with cardiopulmonary bypass].
Yang DX; Yang J; Li LH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1746-8. PubMed ID: 17919378
[TBL] [Abstract][Full Text] [Related]
39. Serologic behavior of S100B protein in patients who are brain dead: preliminary results.
Egea-Guerrero JJ; Revuelto-Rey J; Gordillo-Escobar E; Rodríguez-Rodríguez A; Enamorado-Enamorado J; Ruiz de Azúa López Z; Aldabó-Pallás T; León-Justel A; Murillo-Cabezas F; Vilches-Arenas A
Transplant Proc; 2013; 45(10):3569-72. PubMed ID: 24314961
[TBL] [Abstract][Full Text] [Related]
40. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC
J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
